From: A robust response to combination immune checkpoint inhibitor therapy in HPV-related small cell cancer: a case report
PD-L1
CD4/HPF
CD8/HPF
FOXP3/HPF
CD8/FOXP3
CD8/CD4
Neck primary (pre-treatment)
20%
75
111
31
3.58
1.48
Metastatic brain (post-treatment)
10%
53
69
9
7.67
1.3